---
title: "Agilent Navigates Market Challenges: Q3 Exceeds Expectations As Strategic Investments Pay Off"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/212273036.md"
description: "Agilent Technologies, Inc. reported Q3 revenue of $1.58B, exceeding expectations, despite a 5.6% decline year-over-year. The company forecasts Q4 revenue between $641M and $691M and has revised its FY24 revenue outlook to $450M-$500M. Adjusted EPS of $0.32 surpassed estimates of $0.26. Despite market challenges, CEO Padraig McDonnell noted signs of improvement and ongoing investments in growth opportunities. A shares rose 1.88% to $72.63."
datetime: "2024-08-22T13:44:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/212273036.md)
  - [en](https://longbridge.com/en/news/212273036.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/212273036.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/212273036.md) | [繁體中文](https://longbridge.com/zh-HK/news/212273036.md)


# Agilent Navigates Market Challenges: Q3 Exceeds Expectations As Strategic Investments Pay Off

**Agilent Technologies, Inc.** A shares are trading higher after the company reported third-quarter results yesterday.

Revenue fell 5.6% Y/Y to $1.58 billion, beating the consensus of $1.56 billion. By segment, the Life Sciences and Applied Markets Group (LSAG) segment reported revenue of $782 million, down 8% Y/Y (-7% Y/Y core), with an operating margin of 28.4%.

The Agilent CrossLab Group (ACG) revenue came in at $411 million, up 4% Y/Y (+5% Y/Y core), with an operating margin of 34.0%.

The Diagnostics and Genomics Group (DGG) revenue stood at $385 million, down 9% Y/Y (-8% Y/Y core), with an operating margin of 18.3%.

As of July 31, cash and cash equivalents stood at $1.78 billion. Adjusted EPSof $1.32surpassed the street view of$1.26.

**Outlook**: Agilent forecasts fourth-quarter revenue of $1.641 billion – $1.691 billion (vs. $1.67 billion estimate) and adjusted EPS of $1.38 – $1.42 (vs. street view of $1.44).

For FY24, Agilent revised its revenue outlook to $6.45 billion – $6.5 billion from $6.42 billion – $6.5 billion (vs. $6.46 billion estimate) and adjusted EPS to $5.21 – $5.25 (vs. $5.20 estimate) from $5.15 – $5.25 earlier.

Agilent President and CEO Padraig McDonnell said, “While market conditions continued to be challenged during the quarter, we saw steady signs of improvement as anticipated. We continue to make investments in our most promising growth opportunities.”

“And we are mobilizing the organization to accelerate value creation through strategic transformation initiatives, which will drive margin expansion and growth—and increase our execution capabilities.”

Investors can gain exposure to the stock via **ProShares Nanotechnology E**TF TINY and **VanEck ETF Trust VanEck Morningstar Wide Moat Growth ETF** MGRO.

**Price Action**: A shares are up 1.88% at $142.63 at the last check Thursday.

_Image from Shutterstock_

**Read Next:**

-   **EHangQ2Revenue Skyrockets920%with Record eVTOL Deliveries: Details**

**_Disclaimer:_** _This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors._

### Related Stocks

- [Agilent Technologies, Inc. (A.US)](https://longbridge.com/en/quote/A.US.md)

## Related News & Research

- [Agilent Says FDA Approves Companion Diagnostic for Esophageal or Gastroesophageal Junction Carcinoma](https://longbridge.com/en/news/280633224.md)
- [$100 Invested In Entergy 5 Years Ago Would Be Worth This Much Today](https://longbridge.com/en/news/281075496.md)
- [Buffett says he would care about inflation and the stability of banks if he were at the Fed](https://longbridge.com/en/news/281187041.md)
- [What You Need to Know Ahead of AT&T‘s Earnings Release](https://longbridge.com/en/news/280986472.md)
- [Warren Buffett Says He'd Buy 'A Whole Lot' Of Apple If It Gets Cheaper— And He's Not Losing Sleep Over Cashing Out $100 Billion Stake](https://longbridge.com/en/news/281202027.md)